169 related articles for article (PubMed ID: 33182023)
41. Prognostic and clinicopathological significance of PD-1 expression in hepatocellular carcinoma: a meta-analysis.
Zhang Q; Zhou K; Liang W; Xiong W
J Int Med Res; 2020 Oct; 48(10):300060520962675. PubMed ID: 33100077
[TBL] [Abstract][Full Text] [Related]
42. The prognostic significance of UCA1 for predicting clinical outcome in patients with digestive system malignancies.
Liu FT; Dong Q; Gao H; Zhu ZM
Oncotarget; 2017 Jun; 8(25):40620-40632. PubMed ID: 28380443
[TBL] [Abstract][Full Text] [Related]
43. Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis.
Jiao R; Jiang W; Wei X; Zhang M; Zhao S; Huang G
BMC Cancer; 2020 Jul; 20(1):662. PubMed ID: 32677912
[TBL] [Abstract][Full Text] [Related]
44. Prognostic value of long non-coding RNA ATB in digestive system cancers: A meta-analysis.
Cheng XB; Fu B; Li XZ; Jiang Y
Pathol Res Pract; 2020 Jun; 216(6):152949. PubMed ID: 32307201
[TBL] [Abstract][Full Text] [Related]
45. Prognostic effect of programmed death-ligand 1 (PD-L1) in ovarian cancer: a systematic review, meta-analysis and bioinformatics study.
Wang L
J Ovarian Res; 2019 Apr; 12(1):37. PubMed ID: 31039792
[TBL] [Abstract][Full Text] [Related]
46. Prognostic Role of Programmed Death Ligand-1 Expression in Breast Cancer: A Systematic Review and Meta-Analysis.
Li X; Li M; Lian Z; Zhu H; Kong L; Wang P; Yu J
Target Oncol; 2016 Dec; 11(6):753-761. PubMed ID: 27422273
[TBL] [Abstract][Full Text] [Related]
47. Prognostic and Clinicopathological Value of PD-L1 in Melanoma: A Meta-Analysis.
Xu J; Wang F; Yan Y; Zhang Y; Du Y; Sun G
Am J Med Sci; 2020 Jun; 359(6):339-346. PubMed ID: 32498941
[TBL] [Abstract][Full Text] [Related]
48. Clinical Significance of UCA1 to Predict Metastasis and Poor Prognosis of Digestive System Malignancies: A Meta-Analysis.
Sun XD; Huan C; Qiu W; Sun DW; Shi XJ; Wang CL; Jiang C; Wang GY; Lv GY
Gastroenterol Res Pract; 2016; 2016():3729830. PubMed ID: 28074092
[No Abstract] [Full Text] [Related]
49. Association between PD-L1 Expression and the Prognosis and Clinicopathologic Features of Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Shen M; Chen G; Xie Q; Li X; Xu H; Wang H; Zhao S
Urol Int; 2020; 104(7-8):533-541. PubMed ID: 32623437
[TBL] [Abstract][Full Text] [Related]
50. Clinicopathological and prognostic significance of programmed cell death ligand 1 (PD-L1) expression in patients with esophageal squamous cell carcinoma: a meta-analysis.
Qu HX; Zhao LP; Zhan SH; Geng CX; Xu L; Xin YN; Jiang XJ
J Thorac Dis; 2016 Nov; 8(11):3197-3204. PubMed ID: 28066599
[TBL] [Abstract][Full Text] [Related]
51. Clinical value of Xenopus kinesin-like protein 2 as a prognostic marker in patients with digestive system cancers: a systematic review and meta-analysis.
Wang G; Wang Q; Li Z; Liu C; He X
Onco Targets Ther; 2018; 11():1229-1243. PubMed ID: 29551902
[TBL] [Abstract][Full Text] [Related]
52. Prognostic value of CSN5 in patients with digestive system cancers: a systematic review and meta-analysis.
Guo Y; Gao M; Yao Y; Li J; Chen X; Wang X; Chen Z; Yuan Y; Ma W
BMC Cancer; 2022 Jul; 22(1):812. PubMed ID: 35870903
[TBL] [Abstract][Full Text] [Related]
53. Prognostic Role and Clinical Significance of Tumor-Infiltrating Lymphocyte (TIL) and Programmed Death Ligand 1 (PD-L1) Expression in Triple-Negative Breast Cancer (TNBC): A Systematic Review and Meta-Analysis Study.
Lotfinejad P; Asghari Jafarabadi M; Abdoli Shadbad M; Kazemi T; Pashazadeh F; Sandoghchian Shotorbani S; Jadidi Niaragh F; Baghbanzadeh A; Vahed N; Silvestris N; Baradaran B
Diagnostics (Basel); 2020 Sep; 10(9):. PubMed ID: 32957579
[TBL] [Abstract][Full Text] [Related]
54. Association between raf kinase inhibitor protein loss and prognosis in cancers of the digestive system: a meta-analysis.
Yu M; Wang Q; Ding JW; Yang Z; Xie C; Lu NH
Cancer Biomark; 2014; 14(5):389-400. PubMed ID: 25171481
[TBL] [Abstract][Full Text] [Related]
55. Astrocyte Elevated Gene-1 as a Novel Clinicopathological and Prognostic Biomarker for Gastrointestinal Cancers: A Meta-Analysis with 2999 Patients.
Luo Y; Zhang X; Tan Z; Wu P; Xiang X; Dang Y; Chen G
PLoS One; 2015; 10(12):e0145659. PubMed ID: 26710214
[TBL] [Abstract][Full Text] [Related]
56. High PD-L1 expression in the tumour cells did not correlate with poor prognosis of patients suffering for oral squamous cells carcinoma: A meta-analysis of the literature.
Troiano G; Caponio VCA; Zhurakivska K; Arena C; Pannone G; Mascitti M; Santarelli A; Lo Muzio L
Cell Prolif; 2019 Mar; 52(2):e12537. PubMed ID: 30443950
[TBL] [Abstract][Full Text] [Related]
57. Prognostic Impact of PD-L2 Expression and Association with PD-L1 in Patients with Small-cell Lung Cancer.
Takamori S; Takada K; Azuma K; Jogo Y; Kinoshita F; Kozuma Y; Matsubara T; Haratake N; Akamine T; Toyokawa G; Hirai F; Tagawa T; Okamoto I; Nakanishi Y; Kawahara A; Akiba J; Oda Y; Maehara Y
Anticancer Res; 2018 Oct; 38(10):5903-5907. PubMed ID: 30275217
[TBL] [Abstract][Full Text] [Related]
58. Prognostic and clinicopathological significance of PD-L1 overexpression in oral squamous cell carcinoma: A systematic review and comprehensive meta-analysis.
Lenouvel D; González-Moles MÁ; Ruiz-Ávila I; Gonzalez-Ruiz L; Gonzalez-Ruiz I; Ramos-García P
Oral Oncol; 2020 Jul; 106():104722. PubMed ID: 32330687
[TBL] [Abstract][Full Text] [Related]
59. Increased CD9 expression predicts favorable prognosis in human cancers: a systematic review and meta-analysis.
Koh HM; Jang BG; Lee DH; Hyun CL
Cancer Cell Int; 2021 Sep; 21(1):472. PubMed ID: 34493282
[TBL] [Abstract][Full Text] [Related]
60. Prognostic Value of lncRNA NEAT1 as a New Biomarker in Digestive System Tumors: a Systematic Study and Meta-analysis.
Guo L; Tang Y; Wang Y; Xu H
Expert Rev Mol Diagn; 2021 Jan; 21(1):91-99. PubMed ID: 33550874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
